Drugs for Neglected Diseases initiative (DNDi) and four pharmaceutical firms, Eisai Co Ltd, Shionogi & Co Ltd, Takeda Pharmaceutical Ltd, and AstraZeneca plc have announced the start of a ground-breaking initiative to accelerate and cut the cost of ... PharmaBiz, 1 month ago
New ground-breaking initiative aims to find new treatments for leishmaniasis and Chagas disease - NigerianHerald.com, 1 month ago
Removing Early Barriers To Drugs For Neglected Diseases - Asian Scientist, 2 weeks ago
GLAXOSMITHKLINE has dropped plans to float its HIV drug business. ViiV, its joint venture with Pfizer and Japan's Shionogi, could have been valued at about £15billion but Glaxo said its decision to retain the business reflects its strong positive ...Scottish Daily Express, 1 month ago GSK Cuts Return to Holders From Novartis Asset Swap Morningstar.com, 1 month ago GSK shelves ViiV IPO and rules out mega-merger Pharma Field, 1 month ago
More from: 4 Traders, 4 Traders...and 3 other sources
SHIONOGI ANNOUNCES THAT NALDEMEDINE MET THE PRIMARY ENDPOINT IN ITS FIRST JAPANESE PHASE 3 STUDY FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION IN CANCER PATIENTSNoodls, 1 week ago Naldemedine shows promise in treating OIC in patients with chronic non-cancer pain. News-Medical.Net, 1 month ago Phase IIb Data Show Once-Daily Naldemedine Provides Significant Improvement For Patients With Opioid-Induced Constipation PR Newswire, 1 month ago Shionogi, Inc. Release: Phase IIb Data Show Once-Daily Naldemedine Provides Significant Improvement For Patients With Opioid-Induced Constipation 5/19/2015 ClinicSpace, 1 month ago
* Market wants to wait until Greece's referendum - traders * China market moves focused - traders * Shionogi soars after Credit Suisse's rating hike By Ayai Tomisawa TOKYO, June 30 (Reuters) - Japan's Nikkei share average ...Yahoo! Finance, 4 days ago Nikkei rebounds on buybacks Japan Times, 4 days ago Nikkei edges up but Greece uncertainty still looms Hindu Business Line, 4 days ago Japan shares fluctuate as investors assess possible Greek fallout Malay Mail, 4 days ago
The HIV-oriented joint venture of Pfizer ($PFE), GlaxoSmithKline ($GSK) and Japan's Shionogi is turning to a Chinese manufacturer for a cheap supply of dolutegravir, the active ingredient in its Tivicay. The deal is seen as a way to cut the cost in ...IChainnel, 2 days ago
First developed by Shionogi Inc. under the code name of S-4522 at the end of 1980s, rosuvastatin (rosuvastatin calcium) along with its development, marketing and sales rights, was transferred to AstraZeneca in Jun. 1998 under the code name of ...MarketResearch.com, 1 week ago
Shionogi to Issue of Stock Options as Compensation (Stock Acquisition Rights) to Members of Board of DirectorsNoodls, 1 week ago
Shionogi : Researchers at Shionogi & Co. Ltd. Release New Data on Nerve Tissue Proteins [Development of an Optimized Synthetic and Purification Process of...
Researchers at Shionogi & Co. Ltd. Release New Data on Nerve Tissue Proteins [Development of an Optimized Synthetic and Purification Process of S-2367 (Velneperit), a Novel Neuropeptide Y (NPY) Y5 Receptor Antagonist] By a News Reporter-Staff ...4 Traders, 1 month ago
ViiV Healthcare, a global specialist HIV company, and Desano Pharmaceuticals (Desano), a leading vertically integrated pharmaceuticals company, announced a strategic manufacturing agreement to enable production of dolutegravir in China. The ...PharmaBiz, 12 hours ago China's Desano Pharma to Make API for New HIV Drug for ViiV Financial Content, 1 day ago ViiV Healthcare And Manufacturing Agreement Will Allow Competitive Supply Of Dolutegravir In China And Several Developing Countries BioSpace, 2 days ago GSK share price: HIV unit inks deal with China's Desano Pharmaceuticals Invezz, 2 days ago
Relations between GlaxoSmithKline and China thawing as drug maker announces deal to make HIV medicine with Shanghai firm Desano
By Published: View comments Relations between GlaxoSmithKline and China appear to be thawing as Britain's biggest drug maker announced a deal to make HIV medicine with Shanghai firm Desano Pharmaceuticals. GSK's ViiV Healthcare unit will supply the ...This is Money, 1 day ago GlaxoSmithKline's ViiV Healthcare, Desano to offer China "competitive supply" of HIV drug Tivicay FirstWord Pharma, 2 days ago ViiV Healthcare, Desano to offer China "competitive supply" of GlaxoSmithKline's HIV drug Tivicay FirstWord Pharma, 14 hours ago
on your WebpageAdd Widget >Get your members hooked!